Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Phase III
Amgen (AMGN) And AstraZeneca PLC (AZN) Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 11/26/2014 5:55:16 AM
Novartis AG (NVS) Fires Scientist Who Falsified Data In 6 Research Papers 11/25/2014 5:55:51 AM
Ferring Pharmaceuticals Release: New Data From A Pooled Analysis Shows Improved Overall Survival For Prostate Cancer Patients Treated With FIRMAGON® (Degarelix) Compared To LHRH Agonists 11/25/2014 10:04:28 AM
Intra-Cellular Therapies, Inc. Announces Enrollment Of First Patient In Phase 3 Trial Of ITI-007 For The Treatment Of Schizophrenia 11/25/2014 9:49:31 AM
R-Tech Ueno Received Orphan Drug Designation For Unoprostone Isopropyl (Development Code:UF-021) For The Treatment Of Retinitis Pigmentosa From MHLW 11/25/2014 8:45:52 AM
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 3 Study Of ISIS-SMN Rx In Children With Spinal Muscular Atrophy 11/25/2014 9:03:49 AM
Regeneron (REGN), ReGen Therapeutics Plc (RGT.L) Eczema Drug Dupilumab Gets {3} Breakthrough Therapy Designation 11/20/2014 5:45:20 AM
Amgen (AMGN) Terminates All Rilotumumab Clinical Trials For Advanced Gastric Cancer 11/24/2014 7:43:09 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Publication Of REVEAL-1 Trial Results In The British Journal Of Haematology 11/24/2014 12:38:30 PM
Onxeo Announces Positive DSMB Recommendation For Its Phase 3 Trial With Livatag® In Primary Liver Cancer 11/24/2014 12:28:18 PM
Top 10 Countries For Diabetes Clinical Research 11/19/2014 2:07:48 AM
Immunomedics, Inc. (IMMU) Presents Clinical Data On Novel Antibody-Drug Conjugates For Solid Cancer Therapy 11/21/2014 11:51:27 AM
Immunomedics, Inc. (IMMU) Announces Orphan Drug Designation For Veltuzumab For The Treatment Of Pemphigus 11/21/2014 11:44:10 AM
ZS Pharma (ZSPH) Announces Publication Of Results From Phase 3 Study Of ZS-9 In Patients With Hyperkalemia In The New England Journal of Medicine 11/21/2014 11:21:28 AM
Relypsa, Inc. (RLYP) Announces Data Published In The New England Journal of Medicine For Pivotal Phase 3 Program Of Patiromer FOS For The Treatment Of Hyperkalemia 11/21/2014 11:20:05 AM
1234567
//-->